IRIDEX CORP (IRIX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
IRIX currently has 17.3M outstanding shares. with moderate dilution risk from 3.61M authorized shares representing 20.8% potential dilution. The company has minimally diluted shareholders by 7.67% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 19, 2026 |
10-Q filing | 17.3M shares outstanding |
17M | 3.6M |
| Apr 02, 2026 |
10-K filing | 16.9M shares outstanding |
17M | 4M |
| Nov 12, 2025 |
10-Q filing | 17.0M shares outstanding |
17M | 3.9M |
| Aug 12, 2025 |
10-Q filing | 16.8M shares outstanding |
17M | 4.1M |
| May 13, 2025 |
10-Q filing | 16.7M shares outstanding |
17M | 4.2M |
| Mar 27, 2025 |
10-K filing | 16.4M shares outstanding |
16M | 4.5M |
| Mar 20, 2025 |
8-K filing: IRIDEX Corporation entered into a Securities Purchase Agreement and Note Purchase Agreement with Novel Inspiration International Co., Ltd., issuing 600,000 shares of Series B Preferred Stock at $10.00 per share, initially convertible into 3,000,000 shares of Common Stock, and an initial convertible promissory note in an aggregate principal amount of $4,000,000. ($6.0M proceeds) |
17M | 4.3M |
| Nov 12, 2024 |
10-Q filing | 16.6M shares outstanding |
17M | 4.3M |
| Sep 05, 2024 |
S-3 filing: This S-3 filing relates to the resale of up to 4,952,823 shares of common stock by a selling stockholder, consisting of shares issuable upon conversion of a promissory note and incentive shares issued pursuant to a Securities Purchase Agreement. |
16M | 4.6M |
| Aug 08, 2024 |
10-Q filing | 16.3M shares outstanding |
16M | 0 |
| Aug 05, 2024 |
8-K filing: IRIDEX Corporation entered into a securities purchase agreement with Lind Global Asset Management IX LLC for the issuance and sale of senior convertible promissory notes with an initial principal amount of $4,200,000 and a subsequent contingent note of $1,800,000, which are convertible into common stock at an initial conversion price of $2.44, subject to a floor price of $0.39. |
16M | 0 |
| May 14, 2024 |
10-Q filing | 16.3M shares outstanding |
16M | 0 |
| Mar 29, 2024 |
10-K filing | 16.1M shares outstanding |
16M | 0 |
| Nov 20, 2023 |
10-Q filing | 16.2M shares outstanding |
16M | 0 |
| Aug 10, 2023 |
10-Q filing | 16.0M shares outstanding |
16M | 0 |
| May 11, 2023 |
10-Q filing | 16.0M shares outstanding |
16M | 0 |
| Mar 09, 2023 |
10-K filing | 15.9M shares outstanding |
16M | 26K |
| Nov 10, 2022 |
10-Q filing | 16.0M shares outstanding |
16M | 0 |
| Aug 15, 2022 |
10-Q filing | 15.9M shares outstanding |
16M | 70K |
| May 12, 2022 |
10-Q filing | 15.9M shares outstanding |
16M | 83K |
| Mar 15, 2022 |
10-K filing | 15.4M shares outstanding |
15M | 540K |
| Nov 12, 2021 |
10-Q filing | 15.8M shares outstanding |
16M | 140K |
| Aug 12, 2021 |
10-Q filing | 15.6M shares outstanding |
16M | 320K |
| Jul 09, 2021 |
S-3 filing: The selling stockholder may sell or dispose of up to 1,618,122 shares of common stock. |
14M | 1.6M |
| May 12, 2021 |
10-Q filing | 14.3M shares outstanding |
14M | 0 |
| Mar 23, 2021 |
10-K filing | 15.5M shares outstanding |
16M | 0 |
| Nov 10, 2020 |
10-Q filing | 13.9M shares outstanding |
14M | 0 |
| Aug 07, 2020 |
10-Q filing | 13.8M shares outstanding |
14M | 0 |
| May 12, 2020 |
10-Q filing | 13.8M shares outstanding |
14M | 0 |
| Mar 13, 2020 |
10-K filing | 13.7M shares outstanding |
14M | 0 |